Haloperidol antibody

Principal name

Haloperidol antibody

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Radioimmunoassay (R), Immunocytochemistry/Immunofluorescence (ICC/IF)

Background of Haloperidol antibody

Haloperidol is a butyrophenone antipsychotic drug that has strong central antidopaminergic activity. It has pharmacological effects similar to the phenothiazines. The drug exhibits high affinity dopamine D2 receptor antagonism and slow receptor dissociation kinetics.Haloperidol's negligible affinity for histamine H1 receptors and muscarinic M1 acetylcholine receptors yields an antipsychotic with a lower incidence of sedation, weight gain, and orthostatic hypotension though having higher rates of treatment emergent extrapyramidal symptoms. Tradenames are: Aloperidin, Bioperidolo, Brotopon, Dozic, Duraperidol, Einalon S, Eukystol, Haldol, Halosten, Keselan, Linton, Peluces, Serenace, Serenase, and Sigaperidol.

General readings

Granger, Bernard; Albu, Simona (2005). "The Haloperidol Story". Annals of Clinical Psychiatry 17 (3): 137–40. PMID 16433054.
Seeman, P; Tallerico, T (1998). "Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors". Molecular Psychiatry 3 (2): 123–34. PMID 9577836.
Leysen, JE; Janssen, PM; Gommeren, W; Wynants, J; Pauwels, PJ; Janssen, PA (1992). "In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone". Molecular Pharmacology 41 (3): 494–508. PMID 1372084

3 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

Haloperidol antibody

Haloperidol Rabbit Serum E
0.25 ml / €430.00
  Acris Antibodies GmbH

Haloperidol antibody

Haloperidol Mouse IgG1 HAL101 E, ICC/IF
0.5 mg / €640.00
  Abnova Taiwan Corp.

Haloperidol antibody

Haloperidol Rabbit IgG Serum E
0.125 ml / €360.00
  Novus Biologicals Inc.

3 Item(s)

per page
  • LinkedIn